DETROIT -- Women who are looking for cheap, quick, noninvasive methods of permanent birth control, an option other than hospital-based tubal ligation, are turning to Essure. The nonsurgical method has ...
The institute lists "tubal sterilization" at less than 1 percent, a figure consistent with Gariepy's estimated failure rates for laparoscopic tubal ligations at the one-year mark. By contrast, her ...
Even though it's no longer on the market, new data has emerged around potential side effects of the permanent birth control device Essure. The device, pulled from the US market two years ago amid ...
New surveillance data on women implanted with the ESSURE female sterilization device -- removed from the market in December 2018 -- confirm that substantial numbers suffer abnormal uterine bleeding ...
MOUNTAIN VIEW, Calif., May 2, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure ® procedure, the most effective permanent birth control method available, today introduced ...
For couples who want permanent birth control, the sterilization decision can be a difficult one. Vasectomy for him? Tubal ligation for her? Now, the choice may be easier. A device approved last week ...
Tired of ads? Subscribers enjoy a distraction-free reading experience. Click here to subscribe today or Login. Q: I’m a 35-year-old mother not interested in having any more children. I don’t want to ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--July 27, 2004--Conceptus, Inc. (Nasdaq:CPTS) today provided an update on recent progress in obtaining positive third party payer coverage decisions for Essure(R).
Bayer will pay $1.6 billion to settle lawsuits from thousands of American women who said they developed debilitating long-term health problems from the pharmaceutical giant’s product, the Essure birth ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--Nov. 4, 2004--Conceptus, Inc. (NASDAQ:CPTS) announced today that the Centers for Medicare and Medicaid Services (CMS) has released the Final Rule for the 2005 ...
Even though it’s no longer on the market, new data has emerged around potential side effects of the permanent birth control device Essure. The device, pulled from the US market two years ago amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results